alphaveSGRL₹629.00

Shree Ganesh Remedies Limited

₹ CrorePeersBPLPHARMA JENBURPH KPL MAKERSL NOVARTIND PARNAXLAB SHUKRAPHAR SUNLOC

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	80.5	95.0	104.6
+ Capital Work-in-Progress	16.6	8.3	12.4
+ Other Intangibles	0.1	0.0	0.0
+ Intangibles under Development	0.3	0.4	0.5
+ Non-current Investments	0.2	0.2	0.2
+ Other Non-current Financial Assets	1.2	—	—
Non-current Financial Assets	1.3	—	—
+ Other Non-current Assets	2.0	9.0	1.8
Total Non-current Assets	100.8	114.4	121.9
Current Assets
+ Inventories	25.0	22.0	24.0
+ Current Investments	4.7	18.3	12.5
+ Trade Receivables	20.3	22.3	32.6
+ Cash & Cash Equivalents	15.8	9.9	13.4
+ Other Bank Balances	0.4	0.1	0.1
+ Other Current Financial Assets	0.0	0.6	0.2
Current Financial Assets	41.2	51.1	58.6
+ Other Current Assets	3.9	4.1	3.2
Total Current Assets	70.1	77.5	85.8
Total Assets	170.9	192.0	207.7
Equity
+ Equity Share Capital	12.8	12.8	12.8
+ Other Equity / Reserves	109.3	132.4	150.2
Equity — Owners of Parent	—	145.2	163.0
Total Equity	122.1	145.2	163.0
Liabilities
+ Borrowings — Non-current	29.1	29.5	21.2
Non-current Financial Liabilities	29.1	29.5	21.2
+ Provisions — Non-current	0.3	0.5	0.6
+ Deferred Tax Liabilities	0.6	0.5	1.1
Non-current Liabilities	30.2	30.6	23.0
+ Borrowings — Current	7.2	8.8	9.4
+ Trade Payables	8.2	6.0	9.4
+ Other Current Financial Liab	1.8	1.2	2.0
Current Financial Liabilities	—	16.0	20.9
+ Provisions — Current	0.0	0.0	0.0
+ Current Tax Liabilities	1.5	0.0	0.6
+ Other Current Liabilities	0.0	0.2	0.2
Current Liabilities	—	16.2	21.7
Total Liabilities	—	46.8	44.7
Total Equity & Liabilities	170.9	192.0	207.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.